These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Heart transplantation at a private institution: a two year experience. Halbrook H; Stevens L; Beckman D; Hormuth D; Fehrenbacher J; Herod G J Heart Transplant; 1985 May; 4(3):353-6. PubMed ID: 3916507 [TBL] [Abstract][Full Text] [Related]
3. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ; Rossi AF; Courtney M; Gelb BD J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [TBL] [Abstract][Full Text] [Related]
5. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [TBL] [Abstract][Full Text] [Related]
8. Orthotopic and heterotopic transplantation of the heart: the Cape Town experience. Cooper DK Ann R Coll Surg Engl; 1984 Jul; 66(4):228-34. PubMed ID: 6378042 [TBL] [Abstract][Full Text] [Related]
9. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847 [TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256 [TBL] [Abstract][Full Text] [Related]
13. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients. Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928 [TBL] [Abstract][Full Text] [Related]
14. [Living-donor kidney transplantation in the cyclosporine era]. Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946 [TBL] [Abstract][Full Text] [Related]
15. Effect of early cyclosporine levels on kidney allograft rejection. Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683 [TBL] [Abstract][Full Text] [Related]
16. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. Brann WM; Bennett LE; Keck BM; Hosenpud JD J Heart Lung Transplant; 1998 Apr; 17(4):374-82. PubMed ID: 9588582 [TBL] [Abstract][Full Text] [Related]